Bavarian Nordic A/S (BVNRY)

OTCMKTS: BVNRY · Delayed Price · USD
9.99
+0.28 (2.93%)
Oct 6, 2022 9:45 AM EDT - Market open
2.93%
Market Cap 2.22B
Revenue (ttm) 246.52M
Net Income (ttm) -92.35M
Shares Out 221.59M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE 4.21
Dividend n/a
Ex-Dividend Date n/a
Volume 3,157
Open 9.98
Previous Close 9.71
Day's Range 9.98 - 10.00
52-Week Range 5.85 - 19.31
Beta 1.45
Analysts Buy
Price Target 19.50 (+94.8%)
Earnings Date n/a

About BVNRY

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of ... [Read more...]

Industry Biotechnology
Founded 1992
CEO Paul Chaplin
Employees 868
Stock Exchange OTCMKTS
Ticker Symbol BVNRY
Full Company Profile

Analyst Forecast

According to 14 analysts, the average rating for BVNRY stock is "Buy." The 12-month stock price forecast is 19.5, which is an increase of 94.81% from the latest price.

Price Target
$19.5
(94.81% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines

COPENHAGEN, Denmark, October 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today an agreement with a Latin American country for the supply of the Company's monkeypox vaccine. This is the Company's...

3 days ago - GlobeNewsWire

Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic

COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the board of directors has appointed Luc Debruyne as an observer to the board with the intent to nominate h...

2 weeks ago - GlobeNewsWire

Bavarian Nordic shares jump after reaching smallpox, monkeypox vaccine deal extension

Shares of BAVA, +10.04% jumped 11% as the drugmaker said it signed a contract amendment with Public Health Canada that's valued at up to $434 million over ten years. Under the new contract amendment, th...

2 weeks ago - Market Watch

Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monke...

COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today a revised contract with the Public Health Agency of Canada (PHAC) to supply doses of IMVAMUNE® smallpox vaccine ...

2 weeks ago - GlobeNewsWire

Bavarian Nordic A/S - Articles of Association

Updated Articles of Association for Bavarian Nordic A/S.

4 weeks ago - GlobeNewsWire

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

COPENHAGEN, Denmark, September 7, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 2,150,430 as a consequence of employees' exe...

4 weeks ago - GlobeNewsWire

Bavarian Nordic Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness a...

COPENHAGEN, Denmark, September 7, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the European Health Emergency Preparedness and Response Authority (HERA) has ordered an additional 170,000 d...

4 weeks ago - GlobeNewsWire

Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its COVID-19 Booster Vaccine Candidate

COPENHAGEN, Denmark, September 2, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today the dosing of the first subject in the Phase 3 clinical trial of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 bo...

1 month ago - GlobeNewsWire

3 Top Monkeypox Stocks to Buy Right Now

With the latest outbreak now reported in all 50 states per ABC News, investors may want to consider the top monkeypox stocks to buy right now. From an investment perspective, this latest health threat p...

Other symbols: DGXEBS
1 month ago - InvestorPlace

BVNRY Stock Alert: What to Know as Bavarian Nordic Signs Supply Agreement

Source: angellodeco / Shutterstock.com Bavarian Nordic (OTCMKTS: BVNRY ) stock is on the move Wednesday after the vaccine company signed a supply agreement with PAHO. That supply agreement is for its mo...

1 month ago - InvestorPlace

Bavarian Nordic vows to boost monkeypox vaccine supply to combat shortfall

Bavarian Nordic, the maker of the only approved monkeypox vaccine, said on Wednesday it was exploring the viability of using technically expired doses to help bridge a growing gap between demand and sup...

1 month ago - Reuters

Bavarian Nordic Enters Supply Agreement with PAHO to Support Access to Monkeypox Vaccines in Latin America and the Ca...

COPENHAGEN, Denmark, August 24, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today an agreement with the Pan American Health Organization (PAHO) to facilitate equitable access to the Company's monke...

1 month ago - GlobeNewsWire

Bavarian Nordic Announces First Half 2022 Results

COPENHAGEN, Denmark, August 24, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2022 and released its financial calendar ...

1 month ago - GlobeNewsWire

Elizabeth McKee Anderson Resigns from the Board of Directors of Bavarian Nordic

COPENHAGEN, Denmark, August 23, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that Elizabeth McKee Anderson has decided to step down from the board with immediate effect as she will accept a po...

1 month ago - GlobeNewsWire

Bavarian Nordic (BVNRY) Surges 8.1%: Is This an Indication of Further Gains?

Bavarian Nordic (BVNRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre...

1 month ago - Zacks Investment Research

Here's Why Momentum in Bavarian Nordic (BVNRY) Should Keep going

Bavarian Nordic (BVNRY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

1 month ago - Zacks Investment Research

U.S. negotiates terms with Bavarian Nordic on monkeypox vaccine production

Yahoo Finance's Anjalee Khemlani breaks down the new deal the U.S. and sole monkeypox vaccine maker have reached to speed up vaccine distribution.

1 month ago - Yahoo Finance

Bavarian Nordic signs up U.S. firm for packaging monkeypox vaccine

Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manufacturer to package its Jynneos monkeypox vaccine and the production is expected to begin later this year.

1 month ago - Reuters

U.S. government close to deal allowing Michigan manufacturer package monkeypox vaccine for Bavarian Nordic

The U.S. government is close to a deal that would enable Michigan-based Grand River Aseptic Manufacturing Inc. to package millions of doses of the monkeypox vaccine made by Danish manufacturer Bavarian ...

1 month ago - Market Watch

World's only monkeypox vaccine maker uncertain it can meet demand, Bavarian Nordic CEO warns

That was Rolf Sass Sorensen, a vice president at Bavarian Nordic BAVA, -1.41% BVNRY, -1.18% , which is the only company in the world that produces an approved monkeypox vaccine, in an interview with Blo...

1 month ago - Market Watch

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher

Monkeypox stocks, our topic for today, have had a mostly mixed performance so far in 2022. It is likely, however, that they could benefit from the similar tailwinds enjoyed by companies, such as Pfizer ...

1 month ago - InvestorPlace

Bavarian Nordic Warns on Monkeypox Vaccine Supplies

The Danish company, which makes the Jynneos vaccine, previously said European production would halt for a period while it upgrades a production site.

1 month ago - Barrons

FDA grants emergency authorization allowing monkeypox vaccine by intradermal injection

The Food and Drug Administration granted an emergency authorization that allows healthcare providers to give out the Jynneos monkeypox vaccine to adults intradermally instead of subcutaneously. Injectin...

1 month ago - Market Watch

3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency

The White House has declared monkeypox a public health emergency. Within the last two weeks, California, New York and Illinois making the same declaration already, and many other states are sounding the...

Other symbols: APDNGOVX
2 months ago - InvestorPlace

Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023

COPENHAGEN, Denmark, August 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered a new contract with an undisclosed APAC country for the supply of 350,000 doses of its non-repli...

2 months ago - GlobeNewsWire